about
Benchmarking biomarker-based criteria for Alzheimer's disease: Data from the Swedish Dementia Registry, SveDem.Evaluating amyloid-β oligomers in cerebrospinal fluid as a biomarker for Alzheimer's diseaseHomocysteine levels in chronic gastritis and other conditions: relations to incident cardiovascular disease and dementiaLongitudinal and postural changes of blood pressure predict dementia: the Malmö Preventive Project.Levels of cerebrospinal fluid α-synuclein oligomers are increased in Parkinson's disease with dementia and dementia with Lewy bodies compared to Alzheimer's diseaseCerebral inflammation is an underlying mechanism of early death in Alzheimer's disease: a 13-year cause-specific multivariate mortality study.SveDem, the Swedish Dementia Registry - a tool for improving the quality of diagnostics, treatment and care of dementia patients in clinical practice.Changes in cerebrospinal fluid and blood plasma levels of IGF-II and its binding proteins in Alzheimer's disease: an observational study.Cerebral Microbleeds and White Matter Hyperintensities in Cognitively Healthy Elderly: A Cross-Sectional Cohort Study Evaluating the Effect of Arterial Stiffness.Hepatocyte growth factor in cerebrospinal fluid differentiates community-acquired or nosocomial septic meningitis from other causes of pleocytosisCerebrospinal fluid levels of IL-6 are decreased and correlate with cognitive status in DLB patientsCerebral white matter lesions - associations with Aβ isoforms and amyloid PETPsychosocial behaviour management programme for home-dwelling people with dementia: A cluster-randomized controlled trial.CSF/serum albumin ratio in dementias: a cross-sectional study on 1861 patients.Dementia behaviour management programme at home: impact of a palliative care approach on care managers and professional caregivers of home care services.The Montreal Cognitive Assessment: Normative Data from a Large Swedish Population-Based Cohort.The interactive effect of demographic and clinical factors on hippocampal volume: A multicohort study on 1958 cognitively normal individuals.CSF neurofilament light differs in neurodegenerative diseases and predicts severity and survival.Diabetes mellitus and elevated copeptin levels in middle age predict low cognitive speed after long-term follow-up.Copeptin, a Marker of Vasopressin, Predicts Vascular Dementia but not Alzheimer's Disease.Cerebrospinal fluid tau and amyloid-β1-42 in patients with dementia.Lack of replication of association findings in complex disease: an analysis of 15 polymorphisms in prior candidate genes for sporadic Alzheimer's disease.[Modern dementia care on the rise thanks to national guidelines].Cerebrospinal fluid phospho-tau, total tau and beta-amyloid(1-42) in the differentiation between Alzheimer's disease and vascular dementia.Cobalamin, folate, methylmalonic acid, homocysteine, and gastritis markers in dementia.CT brain findings in clinical dementia investigation--underestimation of mixed dementia.Cerebrospinal fluid levels of heart fatty acid binding protein are elevated prodromally in Alzheimer's disease and vascular dementia.Evaluation of factors of importance for clinical dementia diagnosis.Increased midlife triglycerides predict brain β-amyloid and tau pathology 20 years later.Evaluation of the cerebrospinal fluid amyloid-β1-42/amyloid-β1-40 ratio measured by alpha-LISA to distinguish Alzheimer's disease from other dementia disorders.Biomarkers of microvascular endothelial dysfunction predict incident dementia: a population-based prospective study.Increased blood-brain barrier permeability is associated with dementia and diabetes but not amyloid pathology or APOE genotype.Clusterin in cerebrospinal fluid: analysis of carbohydrates and quantification of native and glycosylated forms.Association between subcortical lesions and behavioral and psychological symptoms in patients with Alzheimer's disease.Increased levels of hyaluronic acid in cerebrospinal fluid in patients with vascular dementia.Atrial fibrillation (AF) and co-morbidity in elderly. A population based survey of 85 years old subjects.Tau and Abeta42 in cerebrospinal fluid from healthy adults 21-93 years of age: establishment of reference values.N-Terminal Prosomatostatin and Risk of Vascular Dementia.No independent association between pulse wave velocity and dementia: a population-based, prospective study.Associations of central and brachial blood pressure with cognitive function: a population-based study.
P50
Q30972921-49CFE5A2-6D45-49D7-B309-64376524F2D0Q31120924-4F99C681-887A-43B1-8B97-ACCB44F0A0FEQ33583592-0DF498B9-534A-4B72-A138-78D76ACAAF2FQ33705284-EE9C6097-AEF3-44A8-AABB-F11E7072AE90Q33822641-037FC6D4-47FD-44CC-86DC-B22F60B0EF32Q34582695-1EF237B3-8D87-4B5D-81AC-FDDE4C269B6AQ35103331-5AB6F156-6FEE-422D-839A-23C02C595612Q35135708-6B68321F-9DC6-491F-8BF9-572F306C2E97Q35773214-80831737-EC35-4B3E-8EEF-6DF6F7247818Q36092775-E18A0238-7D76-420F-8F8C-99EA10AC47FBQ36120659-864F3201-9F26-4758-A9B5-9E8E64E8D433Q36559869-AFCD8076-89B0-4278-AA58-F713803B4D84Q38635180-135F62A3-055F-499A-BD34-2D3BF790E50CQ38639250-4C9D47FF-F9BF-4F03-BB50-17EF7B9EF435Q38677827-435060DF-552E-47A1-AE9F-29F17EFFE51EQ38683922-65EF4C25-3B10-4B42-893F-BBF4150ADA9CQ38732582-90C5D983-BB54-4B68-BAFC-BD97CB067B2CQ39469698-99E8C271-D2A0-4386-B410-4519292C7D5EQ39476125-EE6F0257-B829-4CE1-AB1E-46330887497BQ39850182-2824545F-1EA5-4501-80C2-B89CA41B59B4Q40777128-25BD065A-2529-476D-8959-CA6EBCF3F30AQ43661047-0285F5E1-20F4-41CA-BC14-001F79981873Q43847235-26E1F32E-C5DD-43C2-969E-0845AD849B2EQ44201887-C19B03DB-C069-47FE-8C74-4C9746900098Q44598460-CDD93D82-5827-4741-ABF7-D868E62F8C89Q44845050-D3A12D77-7F3D-409A-8AEB-71D219D168EBQ46181670-50346B4C-487A-4DDD-A9FB-148359D3548EQ46388201-C3F5ECF7-0942-4C22-83E1-B025D659C034Q47288599-58F47869-DBEB-45F6-81ED-9B26EF5D6947Q47996302-6A73B224-E183-41FA-B18D-170DBB050BAEQ48277492-73F600FE-3CEA-4A7A-B31D-5FB300C1DE98Q48369070-0C04B582-B7C2-4BAF-8A5E-3B60FD0362BFQ48642645-5D450E51-A444-472A-8361-4398A6D9D742Q48654934-370805BE-3707-4DFB-94AF-02B207F43EE8Q48659795-E6F16579-BC04-440D-96EF-9E5311C8487EQ48752119-1841D6C6-36DF-46B1-BB02-B09F1D16F4A4Q48784648-B2CDEB23-7DC9-4DAB-A2D3-603DE19D3DF7Q50273018-17F13EDC-ABAC-4465-98F7-502B480C4413Q50575092-18B81B3F-9127-4E1B-A223-45442690A520Q50589805-F9265827-9718-4B7B-92A9-FC5B6676567F
P50
description
Zweeds onderzoekster
@nl
hulumtuese
@sq
researcher
@en
հետազոտող
@hy
name
Katarina Nägga
@ast
Katarina Nägga
@en
Katarina Nägga
@es
Katarina Nägga
@nl
Katarina Nägga
@sl
type
label
Katarina Nägga
@ast
Katarina Nägga
@en
Katarina Nägga
@es
Katarina Nägga
@nl
Katarina Nägga
@sl
prefLabel
Katarina Nägga
@ast
Katarina Nägga
@en
Katarina Nägga
@es
Katarina Nägga
@nl
Katarina Nägga
@sl
P106
P108
P21
P27
P31
P496
0000-0003-0194-8402